Pediatrics · Detroit, MI
NPI
1720364052
Since 2011
Specialty
Pediatrics
Code 208000000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
22201 Moross Rd, Suite 70 Pb2
Detroit, MI, 48236
Phone (313) 343-7979
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$428K
749 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Shweta Saini prescribed most often to Medicare patients was Breyna (Budesonide/Formoterol Fumarate), with 125 prescriptions and refills. In total Shweta Saini wrote 749 Medicare prescriptions that cost $428K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Breyna Budesonide/Formoterol Fumarate | 125 | 230 | 45 | $39K |
| Dupixent Pen Dupilumab | 86 | 86 | Under 11 | $311K |
| Ipratropium Bromide Generic | 78 | 90 | 27 | $1,759 |
| Fluticasone Propionate Generic | 57 | 81 | 25 | $1,299 |
| Azelastine Hcl Generic | 49 | 60 | 18 | $1,001 |
| Montelukast Sodium Generic | 41 | 125 | 16 | $456 |
| Famotidine Generic | 39 | 49 | Under 11 | $364 |
| Spiriva Respimat Tiotropium Bromide | 38 | 52 | Under 11 | $14K |
| Gengraf Cyclosporine, Modified | 34 | 36 | Under 11 | $3,493 |
| Alvesco Ciclesonide | 34 | 67 | Under 11 | $4,488 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 | 26 | 13 | $441 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 25 | 26 | Under 11 | $3,002 |
| Epinephrine Generic | 16 | 16 | Under 11 | $2,100 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 15 | 33 | Under 11 | $3,432 |
| Symbicort Budesonide/Formoterol Fumarate | 14 | 18 | Under 11 | $5,873 |
Brand drugs: 248 claims; generic drugs: 501 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Shweta Saini were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.